Clinical Trials Insight: 700015677

Trial Profile

Clinical Trials Insight: 700015677

Phase of Trial: Phase II

Latest Information Update: 11 Jun 2008

At a glance

  • Drugs MTR 104 (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Sponsors Meditor Pharmaceuticals
  • Most Recent Events

    • 11 Jun 2008 Status changed from in progress to completed based on information from a Meditor Pharmaceuticals media release.
    • 11 Jun 2008 Results have been reported in a Meditor Pharmaceuticals media release, and will be presented at an international conference for migraine in Europe.
    • 06 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top